Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia

Clinical Trial ID NCT00117845

PubWeight™ 0.85‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00117845

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980 30.08
2 Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977 10.69
3 Synergistic antitumor activity of anti-CD25 recombinant immunotoxin LMB-2 with chemotherapy. Clin Cancer Res 2011 0.85
4 Linkage-specific alpha-D-galactosidases from Trichomonas foetus: characterisation of the blood-group B-destroying enzyme as a 1, 3-alpha-galactosidase and the blood-group P1-destroying enzyme as a 1, 4-alpha-galactosidase. FEBS Lett 1975 0.75
Next 100